BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2016
View Archived Issues
Kalvista Pharmaceuticals describes KLKB1 inhibitors
Read More
SatRx discloses first market registration of antidiabetic drug gosogliptin in Russia
Read More
Aptose Biosciences and Crystalgenomics enter global license deal for the development of CG-026806
Read More
Insmed withdraws Arikayce MAA, with plans to resubmit
Read More
Darvulumab monotherapy shows early evidence of clinical benefit in NSCLC patients
Read More
Momenta Pharmaceuticals doses first volunteers in phase I trial for M-281
Read More
Kempharm files amendment request with FDA regarding Apadaz's NDA
Read More
Addex Therapeutics reports positive results on ADX-71441
Read More
Shionogi patents P2X3 and/or P2X2/3 receptor antagonists
Read More
Sichuan Haisco Pharmaceutical discloses anticancer agents
Read More
reMYND develops agents for amyloid-related diseases
Read More
Arrowhead Pharmaceuticals begins phase I/II trial of ARC-521
Read More
Investigators from SIMM and GIBH present EGFR inhibitors
Read More
RN-983 shows promising activity in the ovalbumin allergic mouse model of asthma
Read More
GM-604 receives E.U. orphan drug designation for ALS
Read More
Results presented for emibetuzumab with or without erlotinib in patients with NSCLC
Read More
Mologen shifts from research to product- and market-oriented company
Read More
Joslin Diabetes Center announces collaboration with Sanofi for diabetes treatment exploration
Read More
Alnylam Pharmaceuticals begins phase I trial of ALN-TTRsc02
Read More
Merck & Co. signs definitive agreement to acquire Afferent Pharmaceuticals
Read More
Phase I data on TD-1473 support progression into ulcerative colitis trial
Read More
Vemurafenib may enhance RAI efficacy in BRAF-mutant thyroid cancer patients
Read More
PPMD awards grant to University of Washington to develop gene therapy for Duchenne
Read More
Lilly grants USD 1 million to sponsor development of the ARMR
Read More
Remissions seen with CD19-specific CAR T cells retreatment in pediatric patients with ALL
Read More
Debiopharm International starts phase II trial for Debio-1143
Read More
Venetoclax combined with bortezomib and dexamethasone show acceptable safety profile in MM
Read More
Sophiris Bio discloses results for phase IIa trial of topsalysin
Read More
